Nissui Pharmaceutical Co.,Ltd.
日水製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4550
No filings in 18+ monthsFY2021 (Mar 2022) · J-GAAP · consolidated Source: filing S100OBI9
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2021 (Mar 2022) runs Apr 1, 2021 – Mar 31, 2022.
| Gross margin | 31.6% |
|---|---|
| Operating margin | 9.4% |
| Net margin | 6.9% |
| Return on equity | 3.5%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 3.2% |
| Revenue growth (YoY) | 39.1% |
| EPS (basic) | ¥51.20 |
| EPS growth (YoY) | 74.7% |
| Current ratio | 8.29x |
| Equity ratio | 88.3% |
| Book value / share | ¥1,455.97 |
| Free cash flow | ¥908M |